Clinical Equipoise for Trials of Novel Biologic Therapies, Therapeutic Success Rates, and Predictors of Success: A Meta-Analysis HER2 discordance between primary tumor and CTCs was observed in 18.8% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results